UK sites looking to recruit individuals with Gorlin syndrome for Patidegib Phase III Trial

Are you interested in participating in this Phase III trial? This is a global study of the efficacy and safety of Patidegib Topical Gel, 2%, applied topically twice daily to the face of adult participants with Gorlin syndrome. For more information about the trail and eligibility criteria visit clinicaltrials.gov

Four sites in the UK, London, Oxford, Salford and Glasgow, are now looking to recruit participants with Gorlin syndrome. If you are interested in learning more or wish to make direct contact with a centre near you contact details are listed below